Impact of switching high-sensitivity cardiac troponin assays on risk stratification in suspected acute coronary syndrome
European Heart Journal: Acute Cardiovascular Care · 08.07.2026 · 15 (7) · 545-548
DOI: 10.1093/ehjacc/zuag042 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Heart Journal: Acute Cardiovascular Care, online erschienen am 27.03.2026. Verfasst von Ziwen Li und 20 weiteren Autor:innen. Beteiligte Einrichtung: British Heart Foundation Centre of Research Excellence, University of Edinburgh, Chancellor's Building, Edinburgh EH16 4SA, UK. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Troponin T, Troponin I. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Hospital of Basel, Division of Internal Medicine, Swiss Academy of Medical Sciences.
Abstract (Originalsprache)
Aims
Cardiac troponin is central to risk stratification in patients with suspected acute coronary syndrome. High-sensitivity assays measuring cardiac troponin (hs-cTn) I or T are recommended by international guidelines. However, diagnostic thresholds for these assays are derived from different populations. We aimed to evaluate whether the change in assay influenced risk stratification. Methods and results This is a secondary analysis of the TWITCH-ED study enrolling 25 849 patients with suspected acute coronary syndrome between October 2020 and October 2022. In October 2021, sites changed from an hs-cTnI to an hs-cTnT assay. Study outcomes included discharge from the Emergency Department following a single cardiac troponin measurement, a composite outcome of subsequent myocardial infarction, heart failure hospitalization, or cardiovascular death at 1 year, and all-cause death at 1 year. Patients were stratified as low-risk at presentation using established thresholds. Higher proportions of patients were identified as low-risk (57.3% vs. 17.6%) and discharged following a single troponin measurement (47% vs. 30%) using the hs-cTnI assay, compared to the hs-cTnT assay (P < 0.001 for both). Those identified as low-risk with the hs-cTnT assay were younger (median 52 [inter-quartile range 40–62] vs. 41 [32–51] years) with fewer comorbidities, and had lower rates for the composite outcome (0.8% vs. 0.2%) and all-cause death (2.0% vs. 0.3%) (P < 0.001 for both) at 1 year.
Conclusion
Risk stratification thresholds for hs-cTnI and hs-cTnT assays do not provide equivalent performance. The hs-cTnT assay and threshold identified fewer low-risk patients suitable for discharge, with fewer subsequent cardiovascular events at 1 year.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- British Heart Foundation Centre of Research Excellence, University of Edinburgh, Chancellor's Building, Edinburgh EH16 4SA, UK.
- Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland.
- Usher Institute, The University of Edinburgh, Usher Building, 5-7 Little France Road, Edinburgh EH16 4UX, UK.
- Department Clinical Biochemistry, Royal Infirmary of Edinburgh, Edinburgh, UK.
- Department Clinical Biochemistry, Western General Hospital, Edinburgh, UK.
- Department of Emergency Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK.
ORCID-Profile: Ziwen Li, Jasper Boeddinghaus, Caelan Taggart, Atul Anand, Nicholas L Mills
Förderung
- University Hospital of Basel
- Division of Internal Medicine
- Swiss Academy of Medical Sciences
- Gottfried and Julia Bangerter-Rhyner Foundation
- Swiss National Science Foundation
- Clinical Research Training
- Medical Research Council
- British Heart Foundation
Zitieren
APA
Li, Z., Boeddinghaus, J., Bularga, A., Taggart, C., Wereski, R., Chapman, A. R., Lee, K. K., Doudesis, D., Tuck, C., Fineran, P., Jenks, S., Pattenden, R., Malo, J., Harry, D., Thurston, A. J. F., Tew, Y. Y., McDermott, M., Gray, A., Cruden, N. L. M., …, & Mills, N. L. (2026). Impact of switching high-sensitivity cardiac troponin assays on risk stratification in suspected acute coronary syndrome. European Heart Journal: Acute Cardiovascular Care, 15(7), 545-548. https://doi.org/10.1093/ehjacc/zuag042
Vancouver
Li Z, Boeddinghaus J, Bularga A, Taggart C, Wereski R, Chapman AR, et al. Impact of switching high-sensitivity cardiac troponin assays on risk stratification in suspected acute coronary syndrome. European Heart Journal: Acute Cardiovascular Care. 2026;15(7):545-548. doi:10.1093/ehjacc/zuag042
BibTeX
@article{Li2026,
author = {Li, Ziwen and Boeddinghaus, Jasper and Bularga, Anda and Taggart, Caelan and Wereski, Ryan and Chapman, Andrew R and Lee, Kuan Ken and Doudesis, Dimitrios and Tuck, Christopher and Fineran, Paul and Jenks, Sara and Pattenden, Rebecca and Malo, Jonathan and Harry, Deepak and Thurston, Alexander J F and Tew, Yong Yong and McDermott, Michael and Gray, Alasdair and Cruden, Nicholas L M and Anand, Atul and Mills, Nicholas L},
title = {Impact of switching high-sensitivity cardiac troponin assays on risk stratification in suspected acute coronary syndrome},
journal = {European Heart Journal: Acute Cardiovascular Care},
year = {2026},
volume = {15},
number = {7},
pages = {545--548},
doi = {10.1093/ehjacc/zuag042}
}
EUVIMED